Global New Drug Development Services
International Clinical Research
BIOTrialMed integrates over 300 top-tier clinical centers worldwide through the CSNA and RCO alliances, providing comprehensive CRO services.
International Clinical Research
INTRODUCTION
INTRODUCTION
BioTrialMed (Bochuang Pharmaceutical) is a wholly-owned subsidiary of Boji Pharmaceutical responsible for global clinical research in the United States, serving as a major strategic layout for Boji Pharmaceutical's international development. Leveraging the U.S.-based international Clinical Site Network Alliance (CSNA) and its own resources, BioTrialMed will conduct innovative drug clinical research services in North America, South America, Europe, Australia and other countries and regions.
In addition to providing CRO services, BioTrialMed collaborates with outstanding experts in various therapeutic areas worldwide through the extensive Clinical Site Network Alliance (CSNA) consisting of over 300 research centers, offering Research Consulting Organization (RCO) services.
In addition to providing CRO services, BioTrialMed collaborates with outstanding experts in various therapeutic areas worldwide through the extensive Clinical Site Network Alliance (CSNA) consisting of over 300 research centers, offering Research Consulting Organization (RCO) services.
OUR ADVANTAGES
Global Network Has Extensive Coverage
Through its Clinical Site Network Alliance (CSNA) and Research Consulting Organization (RCO), BIOTrialMed has over 300 top-tier clinical research centers and specialized institutions worldwide, enabling it to deliver comprehensive global CRO services.
Close Cooperation in Professional Fields
In close collaboration with top experts across various therapeutic areas worldwide, BIOTrialMed delivers professional RCO (Research Consulting Organization) services, ensuring high-quality research support across all medical fields.
SERVICE CONTENT
Medical Monitoring and Safety
- Patient Eligibility
- Treatment Training
- Patient Safety Monitoring
- Periodic Coding Review
- Data Monitoring Committee
- Safety Plan Development and Design
- Adverse Event Reporting
- IND
Project Management
- End-to-End Project Management, including: Sponsor Communication, Study Coordination, Timeline, Budget and Training
- Investigator Meeting
- Resource Management
- Vendor Management
- Investigator Fund Management
- Trial Master File (TMF)
- Patient Enrollment
On-Site Monitoring and Management
- Monitoring Plan Development
- Study Center Training
- Study Center Management
- Subject Enrollment
- Study Center Communication
- Problem Management and Reporting Support
- Interim Monitoring Visit
- Patient Eligibility Confirmation and Verification
- Adverse Event Monitoring
Study Initiation
- Feasibility Assessment
- Investigator Identification
- Study Center Qualification Visit
- Regulatory Support and Review
- Budget Negotiation
- Contract Negotiation and Support